Strategikon Pharma
Strategikon Pharma is a biotech company in San Francisco, United States, founded in 2017. It has raised $7.0M across 2 rounds, most recently a $7.0M Series A in February 2024.
Clinical Study Planning - Clinical Trial Business Operations | Clinical Maestro®
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- SaaS
- Website
- strategikon.com
- Total Funding
- $7.0M
- Last Round
- $7.0M Series AFeb 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.
About
Develops Clinical Maestro, AI-powered software suite that reduces clinical trial costs by 80% or more.
Summary
It lists 11–50 employees. It has raised $7.0M in total across 2 rounds, most recently a $7.0M Series A round in Feb 2024. Investors include Osage Venture Partners, Debiopharm Innovation and Hearstlab.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2024
Sign up to see all 2 events
Funding: Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/strategikon-pharma"><img src="https://indexed.vc/api/badge/company/strategikon-pharma" alt="Strategikon Pharma on Indexed.vc" width="260" height="76" /></a>
